Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SQ Grass SLIT-tablet in allergic rhinoconjunctivitis
NCT02245360Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Oct 2014
- Primary completion
- Mar 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of SQ SLIT-tablet in allergic rhinoconjunctivitis (ARC), sponsored by Abbott Laboratories. Started Oct 2014; status: completed.
02
Drugs
SQ SLIT-tablet
03
Conditions
allergic rhinoconjunctivitis (ARC)
Beyond the preview
Go deeper on NCT02245360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02245360.